CB Therapeutics vs Invitris

<p>CB Therapeutics is a cutting-edge biotechnology platform enabling you to design, develop, and manufacture bio-identical molecules through proprietary yeast-based precision fermentation. With a focus on sustainable production, you can access a range of compounds including cannabinoids, psychedelics, and novel food ingredients tailored for neuroscience, clinical research, and food industries. The platform stands out for its scalable and eco-conscious biosynthesis methods.</p> <p>By partnering with CB Therapeutics, you leverage innovations in synthetic biology to meet health and nutrition challenges while improving efficiency and consistency in compound production. Their expanding bio-manufacturing facility supports increasing demand, and their patented downstream processing technology ensures high purity at competitive costs. Whether you focus on mental health therapeutics or sustainable food tech, CB Therapeutics offers a versatile and responsible solution.</p>

<p>Invitris is a cutting-edge biotechnology platform specializing in cell-free protein synthesis. It enables you to design, express, and scale complex proteins faster and with greater flexibility than traditional cell-based methods. With systems optimized for microbial and mammalian protein production, Invitris supports rapid workflows and high-throughput screening, letting you accelerate research and development in biopharmaceuticals, industrial biotechnology, agriculture, and antimicrobial resistance.</p> <p>It provides tools for rapid protein engineering, integrating computational design with high-throughput screening, and supports seamless scalability from picoliter reactions to large-scale manufacturing. Invitris also offers co-development and licensing partnerships to help you bring innovative biotech solutions to market efficiently. The platform is designed to streamline your protein production process with scalable, tunable, and efficient technologies tailored to a variety of life science applications.</p>